Definitive Healthcare (DH) Common Equity (2020 - 2026)

Definitive Healthcare (DH) has reported Common Equity for 7 consecutive years, with $187.9 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 54.32% year-over-year to $187.9 million; the trailing twelve-month figure through Jun 2026 stood at $187.9 million (down 54.32% YoY), and the FY2025 full-year result was $379.0 million, down 37.58% from the prior year.
• Common Equity retreated to $187.9 million in Q2 2026 per DH's latest filing, from $190.7 million in the prior quarter.
• Across five years, Common Equity topped out at $1.5 billion in Q1 2022 and bottomed at $187.9 million in Q2 2026.
• Historically, Common Equity has averaged $924.1 million across 5 years, with a median of $1.0 billion in 2024.
• The sharpest annual moves came in 2022 and 2025: Common Equity gained 26.76% in 2022, then plunged 63.52% in 2025.
• Over 5 years, Common Equity stood at $1.5 billion in 2022, then decreased by 19.08% to $1.2 billion in 2023, then plunged by 49.37% to $607.2 million in 2024, then slumped by 37.58% to $379.0 million in 2025, then plunged by 50.43% to $187.9 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $187.9 million, $190.7 million, and $379.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.